Find uplifting stories about heroes, innovations, and solutions
15415 results for "** glp-1 drugs"
New research reveals that GLP-1 medications like Wegovy improve heart and liver health even in patients who don't lose weight. The discovery could help millions more people access these life-changing drugs.
A biotech company is launching with a groundbreaking mission: using GLP-1 medications to treat substance use disorders instead of weight loss. Baseline Therapeutics could open new hope for millions struggling with addiction.
Scientists have found two promising methods to help people maintain their weight loss after stopping diets or GLP-1 medications like Wegovy. New research shows a daily pill and a probiotic supplement can both help prevent the frustrating cycle of weight regain.
Women taking Ozempic-type drugs with hormone therapy slashed their uterine cancer risk by two-thirds compared to hormones alone. The discovery could spare thousands from surgery and offer new protection against the most common gynecologic cancer.
Ozempic and similar medications may heal arthritis, liver disease, and more by resetting the immune system, not just through weight loss. Scientists are discovering these drugs work throughout the body to reduce harmful inflammation while keeping infection-fighting power strong.
Weight loss medications like Ozempic and Wegovy appear to dramatically reduce cancer risk across multiple types, according to groundbreaking research presented at a major oncology conference. Scientists are racing to understand how these drugs protect against breast, liver, and lung cancers beyond their weight loss effects.
Diabetes medications like Ozempic and Wegovy may help stop cancer from spreading, according to groundbreaking research tracking over 10,000 cancer patients. The study found these drugs reduced the risk of cancer progression by up to 50% for certain tumor types.
New research shows popular weight loss drugs like Wegovy help prevent heart attacks and heal liver disease even in people who don't lose pounds. This discovery could change how millions access life-saving treatment.
Weight loss medications like Ozempic and Mounjaro are showing remarkable promise in fighting addiction to all major substances, from alcohol to opioids. A study of over 600,000 veterans reveals these drugs reduce substance use disorders by blocking the cravings that fuel addiction.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
Medications like Ozempic, originally designed for diabetes, are showing unexpected promise in treating addiction by reducing cravings in the brain. Physician Dhruv Khullar explores how these "moderation molecules" could help millions struggling with substance abuse. #
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Popular weight loss medications like GLP-1 drugs might do more than help people shed pounds. New research suggests they could also improve testosterone levels and sperm quality in men with obesity.
Danish researchers found that popular GLP-1 drugs like semaglutide reduced asthma flare-ups by a quarter and cut inhaler dependence by 14%. The breakthrough suggests these medications do more than just help with weight loss.
New research suggests GLP-1 medications may help treat alcohol, opioid, and drug addictions by quieting cravings in the brain. A study of 600,000 veterans found fewer ER visits and deaths across all substance types.
A five-year study of over 12,000 patients shows that GLP-1 drugs, commonly used for diabetes and weight loss, significantly reduced the spread of four major cancer types. The findings offer new hope for cancer patients, though experts urge caution before prescribing the medications specifically for cancer treatment.
Early research suggests GLP-1 drugs like Ozempic might help treat endometriosis, offering hope to millions who struggle with limited treatment options. Women are already reporting symptom improvements on social media.
A groundbreaking VA study found that GLP-1 medications like Ozempic may reduce substance use disorders across alcohol, opioids, nicotine, and other drugs. For veterans battling addiction alongside diabetes, these findings could change everything.
A groundbreaking study of 600,000 veterans shows GLP-1 medications like Ozempic dramatically reduce substance use disorders and cut drug-related deaths in half. The discovery could revolutionize how we treat addiction.
A massive study of 600,000 veterans found that GLP-1 medications, commonly prescribed for weight loss and diabetes, cut addiction death rates in half. The drugs also reduced the risk of developing substance abuse problems by up to 25% across multiple substances.
Showing 20 of 15415